secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartCore Enterprises, Inc. (HTCR)
CIK:        0001892322
Form:       8-K
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0001493152-24-010333
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartCore signs 13th Go IPO consulting deal with PharmaBio; $800k fees plus warrant
--------------------------------------------------------------------------------

- Signed 13th Go IPO consulting agreement with PharmaBio Corporation, second contract in 2024.
- Expected compensation: $500,000 in initial fees, $300,000 in success fees, and a warrant for 3% of PharmaBio common stock.
- CEO cites recent $9M from warrant sale of a previous Go IPO client; expects 2024 to be strongest year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1892322/000149315224010333/0001493152-24-010333-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1892322/000149315224010333/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-010333

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer